[
  {
    "ts": "2025-10-03T21:50:06+00:00",
    "headline": "Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts",
    "summary": "In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $403.3, indicating a -1.36% shift from the previous trading day.",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-dips-215006403.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6606160e-27d3-30fc-a042-d22faf51182e",
      "content": {
        "id": "6606160e-27d3-30fc-a042-d22faf51182e",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts",
        "description": "",
        "summary": "In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $403.3, indicating a -1.36% shift from the previous trading day.",
        "pubDate": "2025-10-03T21:50:06Z",
        "displayTime": "2025-10-03T21:50:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba",
          "originalWidth": 900,
          "originalHeight": 745,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J2T_cDhaoaaQj0soPS_nNw--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 900,
              "height": 745,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sWMlcbg78JI.iCrZWAER9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-dips-215006403.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-stock-dips-215006403.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T11:50:46+00:00",
    "headline": "Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key",
    "summary": "Vertex Pharmaceuticals (VRTX) shares saw mild movement today, with the stock ticking slightly higher over the past week. Investors seem to be watching recent performance rather than reacting to fresh headlines or business developments for now. See our latest analysis for Vertex Pharmaceuticals. Vertex Pharmaceuticals has traded with a steady hand lately, reflecting cautious optimism from investors as the longer-term view remains promising. While the 1-year total shareholder return is...",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-assessing-valuation-115046522.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "db83796f-5c54-3642-a6bc-d5dca05ccfe2",
      "content": {
        "id": "db83796f-5c54-3642-a6bc-d5dca05ccfe2",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key",
        "description": "",
        "summary": "Vertex Pharmaceuticals (VRTX) shares saw mild movement today, with the stock ticking slightly higher over the past week. Investors seem to be watching recent performance rather than reacting to fresh headlines or business developments for now. See our latest analysis for Vertex Pharmaceuticals. Vertex Pharmaceuticals has traded with a steady hand lately, reflecting cautious optimism from investors as the longer-term view remains promising. While the 1-year total shareholder return is...",
        "pubDate": "2025-10-03T11:50:46Z",
        "displayTime": "2025-10-03T11:50:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ihFoSuY9PLXURl2kI_sV.w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bIz6sh0rX4c7ACsVP8z51w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-assessing-valuation-115046522.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-assessing-valuation-115046522.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T08:00:00+00:00",
    "headline": "3 Growth Stocks That Could Be 10-Baggers in 10 Years",
    "summary": "Air taxis, quantum computing, and gene editing are all promising technologies to invest in for the long haul.",
    "url": "https://www.fool.com/investing/2025/10/03/growth-stocks-that-could-be-10-baggers-10-years/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "88e35ab0-990a-3bad-ab1c-6748ff4bbb00",
      "content": {
        "id": "88e35ab0-990a-3bad-ab1c-6748ff4bbb00",
        "contentType": "STORY",
        "title": "3 Growth Stocks That Could Be 10-Baggers in 10 Years",
        "description": "",
        "summary": "Air taxis, quantum computing, and gene editing are all promising technologies to invest in for the long haul.",
        "pubDate": "2025-10-03T08:00:00Z",
        "displayTime": "2025-10-03T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/95a424c36193595800d804cf70b68f48",
          "originalWidth": 2120,
          "originalHeight": 1414,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bgnkmaetPDDfKWr0Vu9.pg--~B/aD0xNDE0O3c9MjEyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/95a424c36193595800d804cf70b68f48.cf.webp",
              "width": 2120,
              "height": 1414,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mhftQH_aBnI.XGGzEBl8fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/95a424c36193595800d804cf70b68f48.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/03/growth-stocks-that-could-be-10-baggers-10-years/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-growth-stocks-could-10-080000562.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JOBY"
            },
            {
              "symbol": "RGTI"
            },
            {
              "symbol": "CRSP"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]